AKT1 and cancer: Since it was already demonstrated that in vivo Akt-induced hypertrophy could revert muscle wasting in a mouse model of denervation [18], we tested a similar approach in our cancer model, and thus we show for the first time that in vivo Akt/mTORC1 pathway manipulation is able to reinduce hypertrophy in cancer cachexia.